Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
Rutgers, The State University of New Jersey
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Sun Yat-sen University
Fudan University